A comprehensive view of Cancer. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Printing & Publishing Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck's newly approved PAH treatment, Winrevair, forecast to reach sales of US$3.9B by 2029; the robust start to the drug's launch signals a significant boost for the company's future revenue with cancer drug Keytruda's patent expiry looming
Published: April 25, 2024 by FiercePharma
AstraZeneca reports Q1 revenue up 17% year-over-year to US$12.7B, operating profit up 22% to US$3.1B, with oncology sales growing 23% YoY to US$5.1B, metabolic and cardiovascular drug sales increasing 20% YoY to US$3.1B; annual guidance remains unchanged
Published: April 25, 2024 by BioPharma Dive
Labcorp selected as winning bidder for select assets of Invitae, a leading medical genetics firm, pending court approval; deal expected to generate between US$275.0M -US$300.0M annually and close by Q3 2024
Published: April 25, 2024 by Laboratory Corp. of America Holdings (LabCorp)
ANGLE partners with AstraZeneca to enhance cancer drug development using DNA damage response assay; companies to adapt ANGLE's existing Parsortix-based assay for identifying micronuclei in circulating tumor cells
Published: April 24, 2024 by Proactive Investors
US Patent Issued to Bristol-Myers Squibb on April 23 for "[1,2,4triazolo[1,5-apyridinyl substituted indole compounds" (Indian, American Inventors)
Published: April 24, 2024 by U.S. Fed News

Ask us about our Printing & Publishing market view

Trending Chart

Interactive chart with headline count